Edison, NJ, United States of America

Liangquin Guo


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 20(Granted Patents)


Location History:

  • Fords, NJ (US) (1998)
  • Edison, NJ (US) (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Liangquin Guo in Somatostatin Agonists

Introduction

Liangquin Guo is a notable inventor based in Edison, NJ, who has made significant contributions to the field of pharmaceuticals. He holds two patents that focus on somatostatin agonist compounds, which are crucial in the treatment of various medical conditions.

Latest Patents

His latest patents include innovative somatostatin agonists that exhibit high selectivity toward receptor subtype 2. These compounds are designed to provide an improved therapeutic index for treating diabetes, cancer, acromegaly, and retenosis. Many of these compounds are also orally active, which enhances their usability in therapeutic applications. The patents detail specific preferred stereoisomers of the somatostatin agonists and describe processes for their preparation. Additionally, methods and compositions utilizing these compounds as active ingredients are outlined, showcasing the potential impact of his work.

Career Highlights

Liangquin Guo is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

He has collaborated with esteemed colleagues such as Arthur A. Patchett and Lihu Yang, further enhancing the innovative efforts in his field.

Conclusion

Liangquin Guo's contributions to the development of somatostatin agonists represent a significant advancement in medical science. His work continues to pave the way for new therapeutic options in treating serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…